Rodolphe Elineau’s practice focuses on corporate and financial matters, including M&A and corporate governance.

Rodolphe advises both French and foreign companies on strategic and complex transactions. He also frequently advises listed companies on corporate governance matters and in connection with their general shareholders’ meetings, as well as on shareholder activism matters.

Rodolphe joined the firm in 2011 and became a partner in 2020.

Notable Experience

  • General Mills in its pending sale of its European operations to Sodiaal.

  • Vale in the sale of its New Caledonia nickel assets to Prony Resources.

  • Worldline in its €7.8 billion acquisition of Ingenico to create a new world-class leader in payment services.

  • Capgemini in its €5 billion acquisition of Altran Technologies.

  • Thales in its €5.4 billion acquisition of Gemalto; and in the divestment of its general purpose hardware security modules business to Entrust Datacard Corporation.

  • Total in various transactions, including its €2.5 billion acquisition of Direct Énergie; its €950 million acquisition of Saft Groupe; and the sale to the Borealis Group of its fertilizer subsidiaries GPN and Rosier.

  • SK Global Chemical in its €335 million acquisition of Arkema’s Functional Polyolefin business.

  • General Motors in its €2 billion divestment of Opel/Vauxhall and GM Financial’s European operations to PSA Group.

  • Safran in its €2.4 billion divestment of its identity and security activities to Advent International.

  • Goldman Sachs, as financial advisor to the board of directors of Safran, in its € 7.5 billion combination with Zodiac Aerospace.

  • Tikehau Capital in connection with its €610 million rights offering.

  • Bridgepoint in the sale of portfolio company Médipôle Partenaires to Elsan, creating a leader in French health care.

  • Gameloft in connection with Vivendi’s €700 million hostile tender offer.

  • Vallourec in the reorganization of its Brazilian activities and its reserved capital increases in favor of NSSMC and Bpifrance.

  • Lafarge in its €40 billion merger with Holcim to create LafargeHolcim; and in several other M&A transactions, including the divestment by competitive process of €6.5 billion of assets as part of regulatory approval requirements for its merger with Holcim.

  • Medica in its merger with Korian.

  • Sanofi in connection with the divestiture of its direct and indirect stake in the Yves Rocher Group.

See More

Publications